ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Symic Bio Announces Results from SB-030 Trial
americanpharmaceuticacreview
November 03, 2017Symic Bio announced results from the Phase 1/2 SHIELD trial evaluating SB-030, a locally administered therapeutic, in patients with peripheral vascular disease undergoing angioplasty. -
Peanut allergies? There’s a clinical trial looking to fix that
pharmafile
October 18, 2017Aimmune Therapeutics, a biotech company developing treatments for food allergies, announced that it has entered into a clinical trial collaboration with Regeneron and Sanofi to develop its AR101 treatment for peanut allergies.
Pharma Sources Insight January 2025
